These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25275053)

  • 21. The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma.
    Gimeno-Hernández J; Iglesias-Moreno MC; Gómez-Serrano M; Carricondo F; Gil-Loyzaga P; Poch-Broto J
    Acta Otolaryngol; 2011 Aug; 131(8):840-6. PubMed ID: 21492070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer.
    Peters TT; van Dijk BA; Roodenburg JL; van der Laan BF; Halmos GB
    Ann Surg Oncol; 2014 Mar; 21(3):963-70. PubMed ID: 24248531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.
    Breen D; Barlési F; Zemerli M; Doddoli C; Torre JP; Thomas P; Astoul P
    Clin Lung Cancer; 2007 Mar; 8(5):331-4. PubMed ID: 17562233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
    Wanders R; Steevens J; Botterweck A; Dingemans AM; Reymen B; Baardwijk Av; Borger J; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
    Eur J Cancer; 2011 Dec; 47(18):2691-7. PubMed ID: 21733675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidity as predictor poor prognosis for patients with advanced head and neck cancer treated with major surgery.
    Omura G; Ando M; Saito Y; Kobayashi K; Yamasoba T; Asakage T
    Head Neck; 2016 Mar; 38(3):364-9. PubMed ID: 25331962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.
    Göllnitz I; Inhestern J; Wendt TG; Buentzel J; Esser D; Böger D; Mueller AH; Piesold JU; Schultze-Mosgau S; Eigendorff E; Schlattmann P; Guntinas-Lichius O
    Cancer Med; 2016 Nov; 5(11):3260-3271. PubMed ID: 27726294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma.
    Suzuki H; Hanai N; Nishikawa D; Fukuda Y; Koide Y; Kodaira T; Tachibana H; Tomita N; Makita C; Hasegawa Y
    Jpn J Clin Oncol; 2016 Jul; 46(7):646-51. PubMed ID: 27162318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
    Land LH; Dalton SO; Jensen MB; Ewertz M
    Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
    Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
    Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charlson Comorbidity Index does not predict long-term mortality in elderly subjects with chronic heart failure.
    Testa G; Cacciatore F; Galizia G; Della-Morte D; Mazzella F; Russo S; Ferrara N; Rengo F; Abete P
    Age Ageing; 2009 Nov; 38(6):734-40. PubMed ID: 19755712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck cancer in the elderly: a cohort study in 40 patients.
    Sesterhenn AM; Teymoortash A; Folz BJ; Werner JA
    Acta Oncol; 2005; 44(1):59-64. PubMed ID: 15848907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck cancer in the elderly population.
    Siddiqui F; Gwede CK
    Semin Radiat Oncol; 2012 Oct; 22(4):321-33. PubMed ID: 22985815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer.
    Kim YH; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Oral Dis; 2018 Oct; 24(7):1217-1225. PubMed ID: 29804327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia.
    Marchena-Gomez J; Acosta-Merida MA; Hemmersbach-Miller M; Conde-Martel A; Roque-Castellano C; Hernandez-Romero J
    Ann Vasc Surg; 2009; 23(4):458-64. PubMed ID: 19128926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India.
    Baijal G; Gupta T; Hotwani C; Laskar SG; Budrukkar A; Murthy V; Agarwal JP
    Head Neck; 2012 Sep; 34(9):1251-4. PubMed ID: 22076917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.